M. Tubilsky (Tel Aviv, Israel), A. Schols (Maastricht, The Netherlands)
Testosterone supplementation in men with COPD and muscle morphology
J. Svartberg, U. Aasebø, I. Toft, S. Lindal, M. Lorentzen, R. Jorde (Tromsø, Norway)
|  |
Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD)
R. Garrod, J. Marshall, G. W. Hagan, S. Fredericks, P. W. Jones (London, United Kingdom)
|  |
Inflammatory markers in skeletal muscle of low and normal weight COPD patients
M. C. MontesdeOca, S. H. Torres, J. B. De Sanctis, A. Mata, N. Hernández, C. Tálamo (Caracas, Venezuela)
| |
Body composition by bioelectrical impedance predicts mortality in COPD patients
F. Slinde, A. Grönberg, C. P. Engström, L. Hulthén, S. Larsson (Gothenburg, Sweden)
| |
Leptin levels in induced sputum from patients with COPD are sensitive to smoking status
M. Alessi, S. Reitano, M. Profita, A. Bonanno, R. Di Giorgi, A. Bruno, M. Spatafora, V. Bellia, G. Bonsignore, A. M. Vignola (Palermo, Italy)
| |
Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD)
S. H. Torres, M. C. MontesdeOca, J. B. De Sanctis, A. Mata, N. Hernández, C. Tálamo (Caracas, Venezuela)
| |
Vastus lateralis muscle anabolic and inflammatory marker expression in patients with acute COPD exacerbations (AE)
T. Crul, M. A. Spruit, G. Gayan-Ramirez, R. Quarck, R. Gosselink, T. Troosters, F. Pitta, A. Kasran, M. Decramer (Leuven, Belgium)
| |
Comorbid conditions reported in patients with COPD recruited into a global clinical trial (UPLIFT)
D. Tashkin, B. Celli, M. Decramer, D. Burkhart, S. Kesten, C. Cassino (Los Angeles, Boston, Ridgefield, United States Of America; Leuven, Belgium)
| |